Watch the discussion On Demand!
The concept of value-based care continues to play a significant role in healthcare policy discussions. But can value-based care ever be fully realized without value-based research? All too often clinical trial outcomes are statistically significant but clinically meaningless. Even when clinical trials are clinically relevant, the populations studied are not representative or the control arms at time of study design no longer represent the standard of care. Experts from Cardinal Health weigh in on the critical importance of research in driving improved quality and outcomes for patients.
Please note that this is an exhibitor sponsored event and is not eligible for CE credit.
- What defines value?
- Are traditional RCTs valuable?
- Statistically significant but clinically meaningless
- Value-based research – How do we get there
- Solution = pragmatic and adaptive trials, RWE components, reliable accrual-PRN, CIRN
|Bruce Feinberg, Vice President of Clinical Affairs and Chief Medical Officer, Cardinal Health Specialty Solutions|
||Scott Swain, Director of Real-World Evidence and Regulatory Sciences, Cardinal Health Specialty Solutions|
||Kristi Savill, PhD, Director/Principal Scientist, Real-World Evidence & Insights, Cardinal Health|